Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma.
Mitsogiannis IC, Mitsogianni M, Papathanassiou M, Anagnostou M, Tamposis I, Mitrakas L, Samara M, Tzortzis V, Vlachostergios PJ.
Mitsogiannis IC, et al.
J Kidney Cancer VHL. 2022 Sep 29;9(3):29-40. doi: 10.15586/jkcvhl.v9i3.243. eCollection 2022.
J Kidney Cancer VHL. 2022.
PMID: 36310639
Free PMC article.
Review.